Inflammation and wasting in chronic kidney disease: Partners in crime

81Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Protein energy malnutrition (PEM) is often present in patients with chronic kidney disease with or without ongoing renal replacement therapy. Muscle wasting (sarcopenia) is one of the hallmarks of PEM in these patients and recent studies have reported a link between sarcopenia and inflammation. The low-grade inflammation often observed in end-stage renal disease (ESRD) can lead to sarcopenia through an increase in protein catabolism, a decrease in protein syntheses or both. The activation of the ATP-ubiquitin-proteasome pathway, insulin resistance, hypermetabolism, and decreased appetite are all plausible pathophysiological pathyways whereby inflammation can contribute to sarcopenia and PEM. In the present review we discuss these interactions between inflammation and wasting in ESRD patients and explore putative pathways involved in this condition. © 2006 International Society of Nephrology.

Cite

CITATION STYLE

APA

Avesani, C. M., Carrero, J. J., Axelsson, J., Qureshi, A. R., Lindholm, B., & Stenvinkel, P. (2006). Inflammation and wasting in chronic kidney disease: Partners in crime. Kidney International, 70(SUPPL. 104). https://doi.org/10.1038/sj.ki.5001969

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free